From: Long-term ocular damage after recovery from COVID-19: lack of evidence at three months
 | Not hospitalized 7 (SD) | Hospitalized: 14 (SD) | ||
---|---|---|---|---|
 | No Intensive care 12 | Intensive care p value | ||
Age | 37.7 (16.9) | 53.5 (16.8) | 58.5 (23.3) | Â |
Male | 3 (43%) | 6 (50%) | 1 (50%) | Â |
WBC / μl | – | 6.6 (1.8) | 14.3 (8.7) | 0.21 |
Lymphocyte count /μl | – | 1.6 (0.9)a | 1.2 (0.9) | 0.34 |
CRP mg/dl | – | 2.0 (2.1) | 22.6 (10.0) | 0.1 |
IL-6 pg/ml | – | 19.3 (17.6) b | 544.0 (17.0) | 0.008 |
LDH U/l | – | 293.0 (48.4) | 580.0 (19.8) | 0.001 |
CK U/l | – | 97.6 (57.5)c | 700.0 (738.2) | 0.22 |
Oxygen | – | 4 | 2 |  |
Hypertension | – | 3 | 1 |  |
CHD | – | 1 | – |  |
COPD/asthma | – | 1 | – |  |
Diabetes | – | – | 1 |  |
Anosmia | 1 | – | – |  |
Smoker | 2 | 4 | – |  |